Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia

MLA

Phillip Pierce, et al. Paliperidone Palmitate: Japanese Postmarketing Mortality Results in Patients with Schizophrenia. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn953901230&authtype=sso&custid=ns315887.

APA

Phillip Pierce, Srihari Gopal, Adam Savitz, Hong Qiu, Takahito Hino, Michelle Busch, Akiko Fujino, Maju Mathews, Takeshi Katsu, Yoshikazu Maeda, Masayoshi Takahashi, & David Hough. (2016). Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia.

Chicago

Phillip Pierce, Srihari Gopal, Adam Savitz, Hong Qiu, Takahito Hino, Michelle Busch, Akiko Fujino, et al. 2016. “Paliperidone Palmitate: Japanese Postmarketing Mortality Results in Patients with Schizophrenia.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn953901230&authtype=sso&custid=ns315887.